Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes
Authors not listed
University of New Mexico · 2017
Deregulated nutrient-sensing
Cellular senescence
Chronic inflammation
Disabled macroautophagy
Rapamycin / mTOR inhibition
Metformin
Human
Randomized controlled trial
Abstract
The goal of this pilot and feasibility study is to investigate the effects of a short course of metformin therapy on a surrogate marker of cellular senescence(definition) and autophagy(definition) among adult patients with prediabetes. The overall hypothesis is that metformin will have beneficial effects on longevity and quality of life by inducing autophagy downstream of activating adenosine monophosphate-activated protein kinase (AMPK) and inhibiting mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) through potential effects of reduced inflammation, reduced degeneration of muscle and tendon tissue, antineoplastic effects, reduced obesity and hyperglycemia, preserved cardiovascular functions, and/or the prevention of neurodegeneration (such as age-associated dementia). This pilot study will address the following aim:
Demonstrate that metformin therapy will increase cellular autophagy as an inverse correlate of aging as measured by increases in Microtubule-associated protein 1A/1B-light chain 3 (LC3) scores.
Hypothesis 1: In addition to beneficial effects on glycemia, body weight, and body composition, metformin therapy exerts beneficial effects on surrogate measures of autophagy and aging.
Primary outcome: Increased levels of LC3 in leukocytes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Anonymous. (2017). A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes. <em>University of New Mexico</em>. https://clinicaltrials.gov/study/NCT03309007
Vancouver
Anonymous. A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes. University of New Mexico. 2017.
BibTeX
@misc{anon2017ADoubl,
title = {A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes},
author = {Anonymous},
journal = {University of New Mexico},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in Aging 2020
Open access · CC-BY
Nutritional Mediators of Cellular Decline and Mitochondrial Dysfunction in Older Adults
Nature Methods 2024
Open access · OA
Aging research comes of age
University of California, San Francisco 2011
Open access · US-GOV
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
Purdue University 2005
Open access · US-GOV
Dietary Supplements and Exercise in Aging Adults
GeroScience 2021
Open access · CC-BY
Oolonghomobisflavans from Camellia sinensis increase Caenorhabditis elegans lifespan and healthspan
Medicine & Science in Sports & Exercise 1997
Citation only